Migraine and metabolism

Neurological Sciences

Volumn 33, Issue SUPPL. 1, 2012, Pages

  Casucci, G ^a   Villani, V ^b,c   Cologno, D ^d   D'Onofrio, F ^e  

^a Casa di Cura S Francesco   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d Institute of Clinical Neurophysiology   (Italy)

^e S G MOSCATI HOSPITAL   (Italy)

Author keywords

Metabolic syndrome; Migraine; Obesity; Vascular disease

Indexed keywords

ACETYLSALICYLIC ACID; CANDESARTAN; GINKGOLIDE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; OMEGA 3 FATTY ACID; SIMVASTATIN;

CARDIOVASCULAR RISK; CONFERENCE PAPER; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG MECHANISM; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIGRAINE; NERVOUS SYSTEM INFLAMMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; VASCULAR DISEASE;

ANIMALS; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIGRAINE DISORDERS; OBESITY; RISK FACTORS;

EID: 84864199548     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-1047-4     Document Type: Conference Paper

References (65)

1. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ (2005) Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 64:614-620 (Pubitemid 40261888)
2. Stang PE, Carson AP, Rose KM, Mo J, Ephross SA, Shahar E, Szklo M (2005) Headache, cerebrovascular symptoms, and stroke: the atherosclerosis risk in communities study. Neurology 64:1573-1577 (Pubitemid 40617693)
3. Merikangas KR, Fenton BT, Cheng SH, Stolar MJ, Risch N (1997) Association between migraine and stroke in a large-scale epidemiological study of the United States. Arch Neurol 54:362-368 (Pubitemid 27172854)
4. Cook NR, Benseñor IM, Lotufo PA, Lee IM, Skerrett PJ, Chown MJ, Ajani UA, Manson JE, Buring JE (2002) Migraine and coronary heart disease in women and men. Headache 42:715-727 (Pubitemid 35291505)
5. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE (2006) Migraine and risk of cardiovascular disease in women. JAMA 296:283-291 (Pubitemid 44079312)
6. Davey G, Sedgwick P, Maier W, Visick G, Strachan DP, Anderson HR (2002) Association between migraine and asthma: matched case-control study. Br J Gen Pract 52:723-727 (Pubitemid 36187594)
7. Sillanpaa M, Aro H (2000) Headache in teenagers: comorbidity and prognosis. Funct Neurol 15(suppl 3):116-121 (Pubitemid 32051383)
8. Split W, Szydlowska M (1997) Headache in non-insulin dependent diabetes mellitus. Funct Neurol 12:327-332 (Pubitemid 28156650)
9. Rainero I, Limone P, Ferrero M (2005) Insulin sensitivity is impaired in patients with migraine. Cephalalgia 25:593-597 (Pubitemid 41026024)
10. Sattar N, Gaw A, Scherbakova O et al (2003) Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108:414-419 (Pubitemid 36935533)
11. Resnick HE, Jones K, Ruotolo G, Jain AK, Henderson J, Lu W, Howard BV; Strong Heart Study (2003) Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease in nondiabetic American Indians: the Strong Heart Study. Diabetes Care 26:861-867 (Pubitemid 36929356)
12. Takahashi K, Bokura H, Kobayashi S, Iijima K, Nagai A, Yamaguchi S (2007) Metabolic syndrome increases the risk of ischemic stroke in women. Intern Med 46:643-648 (Pubitemid 46845833)
13. Kurl S, Laukkanen JA, Niskanen L, Laaksonen D, Sivenius J, Nyyssönen K, Salonen JT (2006) Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37:806-811 (Pubitemid 43731913)
14. Iso H, Sato S, Kitamura A, Imano H, Kiyama M, Yamagishi K, Cui R, Tanigawa T, Shimamoto T (2007) Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38:1744-1751 (Pubitemid 46847243)
15. Bigal E, Liberman JN, Lipton RB (2006) Obesity and migraine: a population study. Neurology 66:545-550 (Pubitemid 43739885)
16. Aamodt AH, Stovner LJ, Midthjell K, Hagen K, Zwart JA (2007) Headache prevalence related to diabetes mellitus. The Head- HUNT study. Eur J Neurol 14:738-744 (Pubitemid 47012168)
17. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE (2006) Migraine and risk of cardiovascular disease in women. JAMA 296:283-291 (Pubitemid 44079312)
18. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G (2001) Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomized, placebo-controlled, crossover study. BMJ 322:19-22 (Pubitemid 32066251)
19. CasucciG,Villani V, Frediani F (2008)Central mechanismof action of antimigraine prophylactic drugs. Neurol Sci 29:S123-S126 (Pubitemid 351836979)
20. Medeiros FL, Medeiros PL, Valenca MM, Dodick D (2007) Simvastatin for migraine prevention. Headache 47:855-856
21. Buzzi MG, Sakas DE, Moskowitz MA (1989) Indomethacin and acetylsalicylic acid block neurogenic plasma proteins extravasation in rat dura mater. Eur J Pharmacol 165:251-258 (Pubitemid 19181793)
22. Olesen J, Thomsen LL, Iversen H (1994) Nitric oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 15:149-153 (Pubitemid 24156497)
23. Haffner SM (2006) Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and treatment patterns. Am J Med 119(Suppl 1):S3-S9
24. National Cholesterol Education program (NCEP) (2002) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). Third report of the National Cholesterol Education Program (NCEP) Expert panel detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III) final report. Circulation 106:3143-3421
25. Guldiken B, Guldiken S, Taskiran B, Koc G, Turgut N, Kabayel L, Tugrul A (2009) Migraine and metabolic syndrome. The Neurologist 15:55-58
26. Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343-349 (Pubitemid 46184209)
27. Rasmussen BK, Jensen R, Schroll M, Olesen J (1991) Epidemiology of headache in a general population - A prevalence study. J Clin Epidemiol 44:1147-1157
28. Loevinger BL, Muller D, Alonso C, Coe CL (2007) Metabolic syndrome in women with chronic pain. Metabolism 56:87-93 (Pubitemid 44855016)
29. Bigal ME, Lipton RB (2009) The epidemiology, burden and comorbidities of migraine. Neurol Clin 27:321-334
30. FlegalKM,CarrollMD,OgdenCL,CurtinLR(2010) Prevalence and trends in obesity amongUS adults, 1999-2008. JAMA 303:235-241
31. Bigal ME, Lipton RB (2006) Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 67:252-257 (Pubitemid 44305408)
32. Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB (2007) Body mass index an episodic headaches: a population based study. Arch Intern Med 167:1964-1970 (Pubitemid 47606636)
33. Horev A, Wirguin I, Lantsberg L, Ifergane G (2005) A high incidence of migraine with aura among morbidly obese women. Headache 45:936-938 (Pubitemid 41045373)
34. Winter AC, Berger K, Buring JE, Kurth T (2009) Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia 29:269-278
35. Bond DS, Roth J, Nash JM, Wing RR (2011) Migraine and obesity: epidemiology, possible mechanisms and the potential role of weight loss treatment. Obes Rev 12(5):e362-e371
36. Peterlin BL, Rapaport AM, Kurth T (2009) Migraine and obesity: epidemiology, mechanisms, and implications. Headache 50:631-648
37. Peterlin BL, Rosso AL, Rapoport AM, Scher AI (2010) Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 50:52-62
38. Moskowitz MA (1993) Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43(Suppl 3): S16-S20
39. Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P (2006) Pro-inflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 46:200-207
40. Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33:48-56 (Pubitemid 23009909)
41. Gram DX, Hansen AJ, Wilken M, Elm T, Svendsen O, Carr RD, Ahrén B, Brand CL (2005) Plasma calcitonin gene-related peptide is increased prior to obesity, and sensory nerve desensitization by capsaicin improves oral glucose tolerance in obese Zucker rats. Eur J Endocrinol 153:963-969 (Pubitemid 43020248)
42. Peterlin BL, Bigal ME, Tepper SJ, Urakaze M, Sheftell FD, Rapoport AM (2007) Migraine and adiponectin: is there a connection? Cephalalgia 27:435-446 (Pubitemid 46646541)
43. Mohammad-Ali V, Pinkney JH, Coppack SW (1998) Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 22:1145-1158 (Pubitemid 28548534)
44. St-Pierre AC, Cantin B, Mauriege P et al (2005) Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 172:1301-1305 (Pubitemid 40745071)
45. Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings fromthe third National Health and Nutrition Examination Survey. JAMA 287:356-359 (Pubitemid 34251969)
46. Aamodt AH, Stovner LJ, Midthjell K, Hagen K, Zwart JA (2007) Headache prevalence related to diabetes mellitus. The Head- HUNT study. Eur J Neurol 14:738-744 (Pubitemid 47012168)
47. Mitsias PD, Ramadan NM, Levine SR, Schultz L, Welch KM (2006) Factors determining headache at onset of acute ischemic stroke. Cephalalgia 26:150-157
48. Cameron NE, Eaton SE, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973-1988 (Pubitemid 33124042)
49. Kihara M, Low PA (1995) Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurol 32:180-185
50. Split W, Szydlowska M (1997) Headache in non-insulin dependent diabetes mellitus. Funct Neurol 12:327-332 (Pubitemid 28156650)
51. Oral contraceptives and stroke in young women (1975) Associated risk factors. JAMA 231:718-722
52. Elliott D (2008) Migraine and stroke: current perspectives. Neurol Res 30:801-812
53. Kruit MC, van Buchem MA, Hofman PA, Bakkers JT, Terwindt GM, Ferrari MD, Launer LJ (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427-434 (Pubitemid 38129746)
54. Kurth T, Slomke MA, Kase CS, Cook NR, Lee IM, Gaziano JM, Diener HC, Buring JE (2005) Migraine, headache, and the risk of stroke in women: a prospective study. Neurology 64:1020-1026 (Pubitemid 40388455)
55. MacClellan LR, Mitchell BD, Cole JW et al (2006) Familial aggregation of ischemic stroke in young women: the Stroke Prevention in Young Women Study. Genet Epidemiol 30:602-608 (Pubitemid 44630930)
56. Bigal ME, Kurth T, Hu H, Santanello N, Lipton RB (2009) Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology 72:1864-1871
57. Kurth T, Gaziano JM, Cook NR, Logroscino G, Diener HC, Buring JE (2006) Migraine and risk of cardiovascular disease in women. JAMA 296:283-291 (Pubitemid 44079312)
58. Rose KM, Carson AP, Sanford CP et al (2004) Migraine and other headaches: associations with Rose angina and coronary heart disease. Neurology 63:2233-2239 (Pubitemid 40024329)
59. Rose KM, Wong TY, Carson AP, Couper DJ, Klein R, Sharrett AR (2007) Migraine and retinal microvascular abnormalities: the Atherosclerosis Risk in Communities Study. Neurology 68:1694-1700 (Pubitemid 46763257)
60. Chrysohoou C, Pitsavos C, Skoumas J et al (2007) The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study. Int J Cardiol 122:29-33 (Pubitemid 47503343)
61. D'Amico D, Moschiano F, Leone M et al (1998) Genetic abnormalities of the protein C system: shared risk factors in young adults with migraine with aura and with ischemic stroke? Cephalalgia 18:618-621 (Pubitemid 29009491)
62. Martinez-Sànchez P, Martìnez-Martìnez M, Fuentes B, Cuesta MV, Cuéllar-Gamboa L, Idrovo-Freire L, Fernàndez-Dominguez J, Tejedor E (2012) Migraine and hypercoagulable states in ischemic stroke. Cephalalgia 31(16):1609-1617
63. D'andrea G, Bussone G, Allais G (2009) Efficacy of Ginkgolide in the prophylaxis of migraine with aura. Neurol Sci 30(suppl 1) S121-S124
64. Akisn M, Kultursay N, Coker I, Huseynov A (1998) Platelet activating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginko Biloba axtracts reduce PAF concentration in the brain. Biol Neonate 76(4):439-444 (Pubitemid 28505102)
65. Ramsden C, Douglas Mann J, Faurot KR et al (2011) Low omega-6 vs low omega- 6 plus high omega 3 dietary intervention for chronic daily headache: protocol for a randomized clinical trial. Trials 12:97